Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
Recruiting now
Conditions studied: Uterine Fibroid
In brief
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Key facts
- Study ID
- NCT05386615
- Run by
- InSightec
- People needed
- 200
- Starts
- 2016-02-16
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-04-30
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.
Where it is running
- UCLA — Los Angeles, California, United States (enrolling)
- Stanford University — Stanford, California, United States (enrolling)
- Mayo Clinic — Rochester, Minnesota, United States (enrolling)
- Shanghai No. 1 Hospital — Shanghai, China (enrolling)
- Shanghai No.1 Hospital — Shanghai, China (enrolling)
- Huashan Hospital Affiliated to Fudan University — Shanghai, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.